project id: TCGA-ESCA; case submitter id: TCGA-VR-AA7B; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.19; rna integrity number: 9.4; age at index: 65; days to birth: -23915; ethnicity: not reported; gender: female; race: white; vital status: Alive; year of birth: 1946; age at diagnosis: 23915; ajcc clinical m: M0; ajcc clinical n: NX; ajcc clinical stage: Stage IIB; ajcc clinical t: T3; ajcc pathologic m: M1; ajcc pathologic n: N3; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 342.0; icd 10 code: C15.4; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Middle third of esophagus; synchronous malignancy: No; tissue or organ of origin: Middle third of esophagus; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: No; is ffpe: false; composition: Not Reported; days to collection: 822; days to sample procurement: 0; initial weight: 200.0; portion submitter id: TCGA-VR-AA7B-01A-31; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 2.0; percent necrosis: 3.0; percent neutrophil infiltration: 6.0; percent normal cells: 0.0; percent stromal cells: 27.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0;